Table 3 Characteristics of 529 patients receiving sitagliptin plus SU therapy stratified into three age groups

262 (49.5)

190 (35.9)

77 (14.6)

54.9 ± 7.6

69.5 ± 5.7

77.9 ± 2.9

<0.0001^*

143/119

110/80

43/34

0.7853^†

10.3 ± 6.0

15.7 ± 9.6

18.6 ± 10.1

<0.0001^*

25.8 ± 4.7

23.7 ± 3.8

24.4 ± 4.4

<0.0001^*

70.6

75.3

71.4

0.5391^†

17.9

14.7

18.2

0.6295^†

11.5

10.0

10.4

0.8803^†

1.9 ± 1.3

2.0 ± 7.4

1.6 ± 1.1

0.9354^*

4.7 ± 2.5

4.4 ± 2.9

3.0 ± 2.3

0.0007^*

37.7 ± 26.4

35.8 ± 32.2

43.3 ± 21.2

0.2708^*